Shortage reports
Actual shortage:
283 (9%)
Anticipated shortage:
1 (0%)
Avoided shortage:
10 (0%)
Resolved:
2953 (91%)
3247
Discontinuation Reports
To be discontinued:
2 (0%)
Discontinued:
410 (94%)
Reversed:
23 (5%)
435
483 (13%)
16 (6%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-MIRTAZAPINE | 30MG | TABLET | Resolved | 2022-12-22 | 2023-04-28 | 179188 |
| TEVA-MIRTAZAPINE | 30MG | TABLET | Actual shortage | 2023-10-05 | 2024-07-03 | 206407 |
| TEVA-MODAFINIL | 100MG | TABLET | Resolved | 2020-04-02 | 2020-05-14 | 110709 |
| TEVA-MODAFINIL | 100MG | TABLET | Resolved | 2019-09-05 | 2019-10-04 | 93137 |
| TEVA-MODAFINIL | 100MG | TABLET | Resolved | 2024-10-17 | 2024-11-28 | 240522 |
| TEVA-MODAFINIL | 100MG | TABLET | Resolved | 2019-06-18 | 2019-07-31 | 86902 |
| TEVA-MOMETASONE | 0.1% | OINTMENT | Resolved | 2023-06-19 | 2023-07-05 | 195472 |
| TEVA-MOMETASONE | 0.1% | OINTMENT | Resolved | 2021-06-03 | 2021-07-15 | 140387 |
| TEVA-MOMETASONE | 0.1% | OINTMENT | Resolved | 2022-08-18 | 2023-07-21 | 167209 |
| TEVA-MOMETASONE | 0.1% | OINTMENT | Resolved | 2022-01-27 | 2022-03-18 | 153730 |
| TEVA-MOMETASONE | 0.1% | OINTMENT | Resolved | 2024-02-29 | 2024-12-19 | 220986 |
| TEVA-MOMETASONE | 0.1% | OINTMENT | Resolved | 2021-02-05 | 2021-02-25 | 133476 |
| TEVA-MOMETASONE | 0.1% | OINTMENT | Resolved | 2021-07-29 | 2021-09-09 | 143250 |
| TEVA-MOMETASONE | 50MCG | SPRAY, METERED DOSE | Resolved | 2022-05-12 | 2022-09-08 | 160445 |
| TEVA-MOMETASONE | 0.1% | OINTMENT | Resolved | 2021-09-23 | 2021-10-28 | 146095 |
| TEVA-MOMETASONE | 0.1% | OINTMENT | Resolved | 2021-02-25 | 2021-07-15 | 134746 |
| TEVA-MOMETASONE | 0.1% | OINTMENT | Resolved | 2024-04-11 | 2024-10-17 | 224886 |
| TEVA-MOMETASONE | 0.1% | OINTMENT | Resolved | 2024-12-19 | 2025-03-27 | 246104 |
| TEVA-MOMETASONE | 50MCG | SPRAY, METERED DOSE | Actual shortage | 2025-02-13 | 2025-12-11 | 250393 |
| TEVA-MOMETASONE | 0.1% | OINTMENT | Resolved | 2022-02-17 | 2022-04-21 | 155149 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT OLMESARTAN | 20MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117497 |
| ACT OLMESARTAN HCT | 40MG 25MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117519 |
| ACT OLMESARTAN HCT | 20MG 12.5MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117513 |
| ACT OLMESARTAN HCT | 40MG 12.5MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117516 |
| ACT OXYCODONE CR | 5MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65328 |
| ACT OXYCODONE CR | 80MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63992 |
| ACT OXYCODONE CR | 40MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63989 |
| ACT OXYCODONE CR | 20MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63986 |
| ACT OXYCODONE CR | 10MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63983 |
| ACT PROGESTERONE INJECTION | 50MG | SOLUTION | Discontinued | 2025-05-28 | 2025-05-28 | 258417 |
| ACT PROGESTERONE INJECTION | 50MG | SOLUTION | Discontinued | 2025-04-29 | 2025-04-29 | 256082 |
| ACT QUETIAPINE | 300MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258643 |
| ACT QUETIAPINE | 200MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258648 |
| ACT RANITIDINE | 300MG | TABLET | Discontinued | 2020-05-14 | 2020-05-14 | 115082 |
| ACT RANITIDINE | 150MG | TABLET | Discontinued | 2020-05-14 | 2020-05-14 | 115079 |
| ACT RIZATRIPTAN | 10MG | TABLET | Discontinued | 2021-07-22 | 2021-07-22 | 142912 |
| ACT TADALAFIL | Discontinued | 2018-10-22 | 2018-10-22 | 65284 | ||
| ACT TADALAFIL | Discontinued | 2018-10-22 | 2018-10-22 | 65289 | ||
| ACT VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65298 |
| ACT VENLAFAXINE XR | 75.0MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65295 |